Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 905249 | ISIN: US1570851014 | Ticker-Symbol: CU2
Tradegate
06.06.25 | 16:33
1,223 Euro
-7,42 % -0,098
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
CERUS CORPORATION Chart 1 Jahr
5-Tage-Chart
CERUS CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
1,3101,35006.06.
1,2901,35106.06.

Aktuelle News zur CERUS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
29.05.Cerus to present new INTERCEPT Blood System data at ISBT Congress3
29.05.Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan202Presentations and abstracts showcase the broad applicability and expected benefits of the INTERCEPT Blood System for platelets, plasma, IFC, and red blood cells Cerus Corporation (Nasdaq: CERS)...
► Artikel lesen
CERUS Aktie jetzt für 0€ handeln
28.05.Cerus gains regulatory nods for blood safety device in Europe2
28.05.Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 - Next-Generation INTERCEPT Illumination Device216France and Switzerland approve INT200 for use with the INTERCEPT Blood System for Platelets and Plasma Cerus Corporation (Nasdaq: CERS) announced today two in-country regulatory approvals for INT200...
► Artikel lesen
02.05.Cerus targets $194M-$200M revenue in 2025 with double-digit growth and new product launches8
01.05.CERUS CORP - 10-Q, Quarterly Report2
30.04.Cerus Q1 2025 Earnings Preview2
30.04.A Look at Cerus' Upcoming Earnings Report2
10.03.Cantor Fitzgerald maintains Cerus stock $4 target, Overweight rating5
05.03.Cerus receives CE Mark for INTERCEPT Illumination Device2
26.02.CERUS CORP - 10-K, Annual Report2
21.02.Cerus targets 8%-11% revenue growth for 2025 with strong IFC demand and global expansion4
20.02.Cerus GAAP EPS of -$0.01 in-line, revenue of $56.75M beats by $3.8M2
20.02.CERUS CORP - 8-K, Current Report-
06.02.CERUS CORP - 8-K, Current Report-
13.01.Cerus Reports 15% Increase In Full Year Preliminary Product Revenue3
13.01.Cerus expects prelim FY 2024 product revenue to be $180.3M8
13.01.Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update159CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) today announced preliminary product revenue for the fourth quarter and full-year 2024 and provided product revenue guidance for...
► Artikel lesen
13.01.CERUS CORP - 8-K, Current Report-
09.12.24CERUS CORP - 8-K, Current Report-
Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1